Takeda/Lilly Actos Approved With Broader Combo Use Than Other Glitazones
Executive Summary
Takeda/Lilly's antidiabetic Actos will be launched in August with broader combination use than SmithKline Beecham/Bristol-Myers Squibb's "glitazone" agent Avandia.